Multimodal imaging-based diagnostic approach for MRI-negative posterior cortex epilepsy.

Authors:
Mo J; Dong W; Sang L; Zheng Z; Guo Q and 9 more

Journal:
Ther Adv Neurol Disord

Publication Year: 2023

DOI:
10.1177/17562864231212254

PMCID:
PMC10657531

PMID:
38021475

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ther Adv Neurol Disord

Abbreviation: Ther Adv Neurol Disord

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Clinical Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to ide…
Fleischer M; Szepanowski F; Mausberg AK and 6 more (2024) - Transparency Score: 3/6
Efficacy of bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed POEMS syndrome pati…
Fang F; Lan XX; Hu RH and 7 more (2024) - Transparency Score: 3/6
Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis.
Faissner S; Bongert M; Trendelenburg P and 4 more (2024) - Transparency Score: 3/6
Independent risk factors for in-hospital outcome of myasthenic crisis: a prospective cohort study.
Wang Y; Huan X; Zhu X and 9 more (2024) - Transparency Score: 3/6
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifyin…
Butzkueven H; Kalincik T; Patti F and 16 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare that there is no conflict of interest."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was sponsored by the National Natural Science Foundation of China (82071457, 82271495, 82201603, 82201600), Capital’s Funds for Health Improvement and Research (2022-1-1071), and National Key R&D Program of China (2021YFC2401201)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025